Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 20, 2025 • 12:31 PM ET

Date/Time Source News Release
06/03/2025 09:00 AM EDT GlobeNewswire Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
06/02/2025 09:00 AM EDT GlobeNewswire Myriad Genetics Shares New Clinical Data Demonstrating Sensitivity of Precise MRD Across Multiple Cancer Types
05/27/2025 04:05 PM EDT GlobeNewswire Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
05/14/2025 04:45 PM EDT GlobeNewswire Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
05/07/2025 10:59 PM EDT Business Wire Securities Fraud Investigation Into Myriad Genetics, Inc. (MYGN) Announced - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
05/07/2025 04:30 PM EDT GlobeNewswire Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
05/06/2025 04:05 PM EDT GlobeNewswire Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
04/30/2025 08:00 AM EDT GlobeNewswire Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
04/29/2025 09:00 AM EDT GlobeNewswire Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
04/25/2025 04:05 PM EDT GlobeNewswire Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
Page

Additional News

As of June 20, 2025 • 12:31 PM ET

Date/Time Source News Release
06/16/2025 08:25 AM EDT Zacks Should You Hold Myriad Genetics Stock in Your Portfolio Right Now?
06/06/2025 09:09 AM EDT Zacks Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
06/05/2025 11:31 AM EDT Zacks Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?
06/03/2025 12:30 PM EDT Stock Traders Daily Trend Tracker for (MYGN)
05/27/2025 10:15 AM EDT ACCESS Newswire IA Levi & Korsinsky Investigates Myriad Genetics, Inc. (MYGN) Over Possible Securities Fraud
05/27/2025 10:00 AM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation
05/26/2025 11:30 AM EDT ACCESS Newswire IA Ongoing Myriad Genetics, Inc. (MYGN) Investigation: Protect Your Rights - Contact Levi & Korsinsky
05/26/2025 10:00 AM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect
05/25/2025 11:00 AM EDT ACCESS Newswire IA Levi & Korsinsky Investigates Myriad Genetics, Inc. (MYGN) Over Possible Securities Fraud
05/25/2025 10:00 AM EDT ACCESS Newswire IA Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Reach Out
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.